The synthetic peptide was inspired by ACE2, the protein to which the virus that causes COVID-19 binds to invade human cells. The results point to a route for the development of novel antivirals. A ...

An illustration of an antibody disrupting the binding between a virus particle and a receptor on the edge of a membrane. A drug (orange) blocks the SARS-CoV-2 virus (gold sphere with white protruding ...

A new bat coronavirus with the potential for animal-to-human transmission has been discovered by a team of Chinese ...

As we approach the five-year anniversary of the COVID-19 pandemic, it is worth reflecting not only on the paradigm-shifting impact of the initial outbreak, but also on how SARS-CoV-2 continues to ...

COVID-19 affects many organs of the body. The endocrine system is particularly vulnerable because of the expression of the angiotensin-converting enzyme 2 (ACE2) receptor in various endocrine glands.

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against infection by SARS-CoV-2 in the laboratory and eliminated the inflammation caused ...

A team of microbiologists and virologists at Wuhan University, working with colleagues from the Chinese Academy of Sciences, the University of Washington and Humabs BioMed SA, has found that it is ...

Study reveals how the JAK inhibitor lowers ACE2 expression and viral entry in individuals with a genetic risk variant linked to autoimmune diseases. Study: Tofacitinib Mitigates the Increased SARS-CoV ...

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology. This review explores the dual ...